Orlando, Florida

Orlando, Florida 32819

1 studies enrolling now · 12 studies all time

What they study most

Apathy in Dementia, Diabetic Macular Edema (DME), Healthy Participants, Hepatic Impairment, Idiopathic Hypersomnia, Narcolepsy Type 1, Narcolepsy Type 2, Panic Disorder, Parkinson Disease, Renal Impairment, Seizures

Studies at this site

• A Long-term Extension Study of ORX750 in Participants With Narcolepsy and Idiopathic Hypersomnia — Recruiting now
• A Study to Evaluate the Efficacy and Safety of 2 Doses of EYE103 Compared With Ranibizumab (0.5 mg) in Participants With DME — Running, not enrolling
• A Study to Evaluate Efficacy, Safety, and Tolerability of Darigabat in Participants With Panic Disorder — Stopped early
• A Trial of the Safety, Tolerability, and Pharmacodynamics of CVL-871 in Subjects With Dementia-Related Apathy — Stopped early
• An Open-label Extension Trial of CVL-865 as Adjunctive Therapy in the Treatment of Focal Onset Seizures — Stopped early
• A Trial of the Efficacy and Safety of CVL-865 as Adjunctive Therapy in the Treatment of Focal Onset Seizures — Completed
• A Study to Evaluate the Effect of Hepatic Impairment on the Pharmacokinetics of Emraclidine — Completed
• A Study to Evaluate Pharmacokinetic and Safety Trial of Emraclidine in Participants With Renal Impairment Compared With Participants With Normal Renal Function — Completed
• Multiple-dose Trial to Determine the Clinical Bioequivalence Between Tavapadon Tablets in Participants With Parkinson's Disease — Completed
• Open-label Trial to Evaluate the Effect Carbamazepine on Darigabat Pharmacokinetics in Healthy Adult Participants — Completed
• To Evaluate the Pharmacokinetics (PK) and Safety of Tavapadon in Participants With Mild and Moderate Hepatic Impairment Compared to Participants With Normal Hepatic Function — Completed
• Relative Bioavailability Study of Ropinirole Implants in Parkinson's Patients on L-Dopa Switched From Oral Ropinirole — Stopped early